logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
F

Francesca Palandri

hannover medical school

50H-index
533Paper Count
9.3KCitation Count
Published Papers 136
Publication Date
logo
TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis
errBlood
IF23.1
err2026-07-02
err0
PREAI
errNaveen Pemmaraju; Adam J. Mead; Tim CP Somervaille; Francesca Palandri; Steffen Koschmieder; Robert Delage; Jean-Jacques Kiladjian; Christopher Benton; Srinivas K. Tantravahi; Noa Lavi; Su-Peng Yeh; Maria Teresa Gomez Casares; Emanuele Ammatuna; Andrew McDonald; Sung-Soo Yoon; Keita Kirito; Timothy Devos; Andrew Perkins; Atanas Radinoff; Omur Gokmen Sevindik
errShare
errSave
A dynamic prognostic model for Polycythemia Vera long-terms outcomes in patients treated with Ruxolitinib
errBlood Advances
IF7.1
err2026-06-15
err0
errOAAI
errFrancesca Palandri; Alessandra Dedola; Giovanni Caocci; Elena Rossi; Elena M. Elli; Chiara Sartor; Roberto Latagliata; Novella Pugliese; Erika Morsia; Gianni Binotto; Francesco Mendicino; Alessia Tieghi; Giulia Benevolo; Bruno Martino; Alessandra D’Addio; Mario Tiribelli; Daniela Cilloni; Monica Crugnola; Fabrizio Cavalca; Emilia Scalzulli
errShare
errSave
Clinical benefit and predictors of response to momelotinib after ruxolitinib failure: A cooperative real-world study
errCancer
IF5.1
err2026-05-12
err0
errOAAI
errFrancesca Palandri MD, PhD; Monia Marchetti MD, PhD; Elena M. Elli MD; Alessandro Isidori MD; Ilaria Gianesello MD; Chiara Sartor MD, PhD; Novella Pugliese MD; Maria Di Perna MD; Erika Morsia MD; Susanna Gallo MD; Federico Itri MD; Vittorio Montefusco MD; Elena Crisà MD; Annalisa Biagi MD; Eloise Beggiato MD; Olga Mulas MD, PhD; Giulia Benevolo MD; Elisabetta Abruzzese MD; Marco Santoro MD; Alessandra Iurlo MD; Elisabetta Calistri MD; Marco Rossi MD; Bruno Martino MD; Mario Tiribelli MD, PhD; Carmen Fava MD, PhD; Arbana Dizdari MD; Monica Crugnola MD; Andrea Duminuco MD, PhD; Amedeo Votto MD; Selene Guerzoni MD; Giovanni Caocci MD, PhD; Fabrizio Pane MD, PhD; Francesco Lanza MD, PhD; Filippo Branzanti MSc; Alessandra Dedola MD; Flavia Salvatore MD; Florian H. Heidel MD, PhD; Massimo Breccia MD, PhD; Giuseppe A. Palumbo MD, PhD; Andrew T. Kuykendall MD; Alessandro Lucchesi MD, PhD; Sara Galimberti MD, PhD
errShare
errSave
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study
errBlood Advances
IF7.1
err2026-05-02
err0
errOAAI
errHarinder Gill; Abdulraheem Yacoub; Aaron T. Gerds; Jake Shortt; James M. Rossetti; Adam J. Mead; Joachim R Göthert; Steffen Koschmieder; Joanne Ewing; Anna Halpern; Francesca Palandri; Francesco Passamonti; Ruben Mesa; Monia Marchetti; Claire Harrison; Alessandro M. Vannucchi; Justin M. Watts; John C. Wood; David M. Ross; Jennifer Peppe
errShare
errSave
MDM2 inhibitors in myeloid cancers: from basic biology to clinical use in myeloproliferative neoplasms
errLeukemia
IF13.4
err2026-05-01
err0
errOAAI
errAl-Ali, Haifa K.; Heidel, Sarah T.; Palandri, Francesca; Heidel, Florian H.
errShare
errSave
Association Between Transfusion Status, Hemoglobin Levels, and Patient-Reported Outcomes in Myelofibrosis: A Post Hoc Clinical Trial Analysis
errCancer Medicine
IF3.1
err2026-04-10
err0
errOAAI
errRuben Mesa; Jeanne M. Palmer; Francesca Palandri; Lucia Masarova; Claire N. Harrison; Flora Mazerolle; Manal M'hari; Tom Liu; Shiyuan Zhang; Anna Cardellino; Zhaohui Wang; Catherine E. Ellis; Dwaipayan Patnaik; Antoine Regnault; Thomas W. LeBlanc
errShare
errSave
POIESIS: a phase III study of add-on navtemadlin in JAK inhibitor-naïve myelofibrosis patients with a suboptimal response to ruxolitinib
errFuture Oncology
IF2.6
err2026-03-07
err0
PREAI
errPankit Vachhani; Abdulraheem Yacoub; Raajit Rampal; Terrence Bradley; Claire Harrison; Tania Jain; Andrew Kuykendall; Francesca Palandri; John Mascarenhas; Haifa Al-Ali; Francesco Passamonti; Wayne Rothbaum; Srdan Verstovsek; Florian H. Heidel
errShare
errSave
Phase 2 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat for essential thrombocythemia
errBlood Advances
IF7.1
err2026-03-03
err0
errOAAI
errHarinder Gill; Francesca Palandri; David M. Ross; Joachim R. Göthert; Tara Cochrane; Stephen R. Larsen; Anna B. Halpern; Jake Shortt; James M. Rossetti; James Liang; Monia Marchetti; Andrew J. Wilson; Andrew J. Innes; Merit Hanna; Nicola Vianelli; William S. Stevenson; Alessandro M. Vannucchi; Maria Kleppe; Jessica Flynn; Georges Natsoulis
errShare
errSave
Overall survival with momelotinib vs. best available therapy in patients with ruxolitinib-experienced myelofibrosis: a matching-adjusted indirect comparison
errAnnals of Hematology
IF2.4
err2026-02-21
err0
errOAAI
errFrancesca Palandri; Venediktos Kapetanakis; Balázs Dobi; Massimo Breccia; Giuseppe A. Palumbo; Elisabetta Abruzzese; Massimiliano Bonifacio; Mario Tiribelli; Elena Maria Elli; Erika Morsia; Filippo Branzanti; Catherine E. Ellis; Nicholas Ballew; Tom Liu; Kelesitse Phiri; Fulya Sen Nikitas; Shiyuan Zhang; Dwaipayan Patnaik
errShare
errSave
Spleen volume reduction and transfusion independence with momelotinib vs ruxolitinib and associated overall survival with momelotinib in JAK inhibitor–naive patients with myelofibrosis and anemia: subgroup analyses of SIMPLIFY-1
errClinical Lymphoma Myeloma and Leukemia
IF2.7
err2026-02-14
err0
errOAAI
errFrancesca Palandri; Nicolaas P.M. Schaap; Jerome Rey; Nikolas von Bubnoff; Andreas Reiter; Juan Carlos Hernandez-Boluda; Timothy Devos; Lars Nilsson; Bethan Psaila; Donal P. McLornan; Bryan Strouse; Shiyuan Zhang; Bharat Patel; Jessica Lim; Dwaipayan Patnaik; Stephen T. Oh
errShare
errSave
The Influence of Patient Engagement and Self-Efficacy on Self-Care in Myeloproliferative Neoplasms: A Mediation Analysis
errEuropean Journal of Oncology Nursing
IF2.7
err2025-11-17
err0
errOAAI
errValentina Biagioli; Alessandro Inzoli; Antonella Barone; Alessandra Iurlo; Paola Guglielmelli; Francesca Palandri; Barbara Mora; Stefana Impera; Silvia Betti; Marco Santoro; Vittorio Rosti; Giovanni Barosi
errShare
errSave
Hollow fiber flow field-flow fractionation enables high-quality Extracellular Vesicle isolation from minimal plasma samples in polycythemia vera liquid biopsy
errTalanta
IF6.1
err2025-10-17
err0
errOAAI
errGhazal Narimanfar; Anna Placci; Filippo Maltoni; Stefano Giordani; Gianluca Storci; Barbara Roda; Andrea Zattoni; Pierluigi Reschiglian; Massimiliano Bonafè; Francesca Palandri; Valentina Marassi; Lucia Catani
errShare
errSave
Treatment persistence and overall survival in myelofibrosis treated with ruxolitinib were not affected by the covid-19 pandemic, despite the reduced starting dose: Analysis of AIFA registries
errAnnals of Hematology
IF2.4
err2025-09-20
err0
errOAAI
errMassimo Breccia; Simone Celant; Francesca Palandri; Francesco Passamonti; Pier Paolo Olimpieri; Valentina Summa; Annalisa Guarcello; Giuseppe Alberto Palumbo; Fabrizio Pane; Paola Guglielmelli; Pierluigi Zinzani; Paolo Corradini; Pierluigi Russo
errShare
errSave
Real-world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study
errBritish Journal of Haematology
IF3.8
err2025-08-25
err0
PREAI
errElisa Lucchini; Nicola Vianelli; Ugo Consoli; Giuseppe Carli; Valentina Carrai; Monica Carpenedo; Valerio De Stefano; Gianluca Gaidano; Francesca Palandri; Giuseppe Auteri; Elena Rossi; Andrea Patriarca; Vanessa Innao; Gessica Marchesini; Mario Ballerini; Maria Chiara Rossetti; Giulia Mosini; Patrizia Sciancalepore; Jacopo Agnelli Giacchello; Pellegrino Musto; Elena Rivolti; Giulia Soverini; Alessandra Borchiellini; Cristina Clissa; Fabrizio Pane; Sara Galimberti; Vincenzo Pavone; Antonella Poloni; Francesco Buccisano; Maurizio Musso; Paola Fazi; Francesca Paoloni; Livia Gorreo Renzulli; Francesco Zaja
errShare
errSave
Revised “iRR6” model in intermediate-1 risk myelofibrosis patients treated with ruxolitinib
errCancer
IF5.1
err2025-08-21
err0
errOAAI
errFrancesca Palandri MD, PhD; Filippo Branzanti MSc; Massimiliano Bonifacio MD, PhD; Elena M. Elli MD; Erika Morsia MD; Mirko Farina MD; Mario Tiribelli MD, PhD; Giulia Benevolo MD; Eloise Beggiato MD; Bruno Martino MD; Giovanni Caocci MD; Novella Pugliese MD; Alessia Tieghi MD; Monica Crugnola MD; Gianni Binotto MD; Francesco Cavazzini MD; Elisabetta Abruzzese MD; Alessandro Isidori MD; Alessandra Dedola MD; Emilia Scalzulli MD; Andrea Duminuco MD, PhD; Luca Tosoni MD; Alda Strazimiri MD; Roberto M. Lemoli MD, PhD; Daniela Cilloni MD, PhD; Monica Bocchia MD; Fabrizio Pane MD, PhD; Chiara Sartor MD, PhD; Florian H. Heidel MD, PhD; Massimo Breccia MD, PhD; Giuseppe A. Palumbo MD, PhD; Andrew T. Kuykendall MD
errShare
errSave
Exploring thromboembolic risk factors in polycythemia vera: from current evidence to PROSPERO study design
errAnnals of Hematology
IF2.4
err2025-07-18
err0
errOAAI
errValerio De Stefano; Francesco Passamonti; Francesca Palandri; Francesco Ramundo; Elena Rossi; Silvia Betti; Lorenzo Fagiolo; Paola Guglielmelli; Davide Pio Abagnale; Novella Pugliese; Daniele Cattaneo; Alessandra Iurlo; Filippo Branzanti; Alessandra Dedola; Hillary Catellani; Alessia Tieghi; Marco Basso; Elisabetta Calistri; Elena Maria Elli; Elena Masselli; Erika Morsia; Giulia Benevolo; Massimo Breccia; Vincenza de Fazio; Maria Di Perna; Monia Marchetti; Marco Santoro; Agostino Tafuri; Chiara Castiglioni; Chiara Rotella; Sergio Siragusa; Alessandro Maria Vannucchi
errShare
errSave
Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial
errNATURE MEDICINE
IF50
err2025-03-10
err2
errOAAI
errRampal, Raajit K.; Grosicki, Sebastian; Chraniuk, Dominik; Abruzzese, Elisabetta; Bose, Prithviraj; Gerds, Aaron T.; Vannucchi, Alessandro M.; Palandri, Francesca; Lee, Sung-Eun; Gupta, Vikas; Lucchesi, Alessandro; Oh, Stephen T.; Kuykendall, Andrew T.; Patriarca, Andrea; alvarez-Larran, Alberto; Mesa, Ruben; Kiladjian, Jean-Jacques; Talpaz, Moshe; Scandura, Joseph M.; Lavie, David; Harris, Morgan; Kays, Sarah-Katharina; Li, Qing; Boxhammer, Rainer; Brown, Barbara; Jegg, Anna-Maria; Harrison, Claire N.; Mascarenhas, John
errShare
errSave
Anemia and blood transfusions in myelofibrosis: economic and organizational impact on Italian patients, caregivers and hospitals
errFRONTIERS IN ONCOLOGY
IF3.3
err2025-03-07
err0
errOAAI
errPalandri, Francesca; Inzoli, Alessandro; Barone, Antonella; Dordoni, Daniela; Formenti, Elisa; D'Elia, Giorgio Corradini; Aramburu, Victoria Lucia Rabsiun; Palumbo, Giuseppe Alberto; Breccia, Massimo
errShare
errSave
Disease Phenotype Significantly Influences the Outcome After Discontinuation of Ruxolitinib in Chronic Phase Myelofibrosis
errclinical lymphoma myeloma leukemia
IF0
err2025-03-04
err0
errOAAI
errFrancesca Palandri; Massimo Breccia; Erika Morsia; Elena M. Elli; Giulia Benevolo; Mario Tiribelli; Eloise Beggiato; Mirko Farina; Giovanni Caocci; Novella Pugliese; Alessia Tieghi; Monica Crugnola; Gianni Binotto; Francesco Cavazzini; Elisabetta Abruzzese; Alessandro Isidori; Alessandra Dedola; Alessandra Iurlo; Roberto M. Lemoli; Daniela Cilloni; Filippo Branzanti
errShare
errSave
Impact of calreticulin mutations on treatment and survival outcomes in myelofibrosis during ruxolitinib therapy
errANNALS OF HEMATOLOGY
IF2.4
err2025-01-20
err0
errOAAI
errPalandri, Francesca; Branzanti, Filippo; Morsia, Erika; Dedola, Alessandra; Benevolo, Giulia; Tiribelli, Mario; Beggiato, Eloise; Farina, Mirko; Martino, Bruno; Caocci, Giovanni; Pugliese, Novella; Tieghi, Alessia; Crugnola, Monica; Binotto, Gianni; Cavazzini, Francesco; Abruzzese, Elisabetta; Isidori, Alessandro; Scalzulli, Emilia; D'Agostino, Domenico; Caserta, Santino; Nardo, Antonella; Lemoli, Roberto Massimo; Cilloni, Daniela; Bocchia, Monica; Pane, Fabrizio; Heidel, Florian H.; Palumbo, Giuseppe A.; Breccia, Massimo; Elli, Elena M.; Bonifacio, Massimiliano
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
A
Antonio Gasbarrini
H-index: 145 · Papers: 3.8K
C
Claudio Franceschi
H-index: 136 · Papers: 1.2K
A
Alessandro Rambaldi
H-index: 125 · Papers: 1.5K
M
Moshe Talpaz
H-index: 124 · Papers: 1.3K
T
Tiziano Barbui
H-index: 121 · Papers: 958
View more